Position in BIIB
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$247,464,699
-$9,409,776 QoQ
Shares Held
1,349,832
-7.5% QoQ
Ownership
0.914%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.9658890884199.ToString("F0")%
Shared 0.ToString("F0")%
None 8.034110911580107.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $25,087,571,930 across 12 Drug Manufacturers - General names. BIIB ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
25,849,978 | $5,098,132,659 | |
| 2 | LLY |
ELI LILLY & Co
|
5,379,364 | $4,947,777,626 | |
| 3 | JNJ |
Johnson & Johnson
|
19,347,862 | $4,729,391,386 | |
| 4 | ABBV |
AbbVie Inc.
|
12,159,427 | $2,644,553,777 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,538,545 | $2,350,291,577 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,464,889 | $1,458,491,578 | |
| 7 | AMGN |
Amgen Inc
|
3,870,863 | $1,361,963,146 | |
| 8 | PFE |
Pfizer Inc
|
43,505,563 | $1,221,636,207 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $247,464,699 | 1,349,832 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $256,874,475 | 1,459,597 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $223,203,331 | 1,593,399 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $181,705,620 | 1,446,816 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $175,843,094 | 1,285,027 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $188,092,668 | 1,230,007 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $242,678,568 | 1,251,953 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $294,441,999 | 1,270,132 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $281,983,662 | 1,307,720 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $342,895,090 | 1,325,096 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $344,156,436 | 1,339,078 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $390,108,056 | 1,369,521 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $377,716,821 | 1,358,547 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $382,332,089 | 1,380,659 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $381,676,233 | 1,429,499 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $296,930,521 | 1,455,970 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $303,340,026 | 1,440,361 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $325,830,553 | 1,358,080 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $397,939,405 | 1,406,196 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $479,823,568 | 1,385,692 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $334,565,893 | 1,195,946 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $301,293,862 | 1,230,474 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $361,745,330 | 1,275,188 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $350,606,348 | 1,310,433 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $398,791,609 | 1,260,483 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||